Literature DB >> 16990995

Leptomeningeal familial amyloidosis: A rare differential diagnosis of leptomeningeal enhancement in MRI.

P P Urban, C Hertkorn, J M Schattenberg, J Gawehn, S Hägele, M Wunsch, K Altland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16990995     DOI： 10.1007/s00415-006-0169-0

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  16 in total

1.  Neuroimaging features of spontaneous intracranial hypotension.

Authors:  L Spelle; A Boulin; C Tainturier; A Visot; P Graveleau; L Pierot
Journal:  Neuroradiology       Date:  2001-08       Impact factor: 2.804

2.  Cranial pachymeningitis: an unusual manifestation of Wegener's granulomatosis.

Authors:  Adel G Fam; Elana Lavine; Liesly Lee; Bayardo Perez-Ordonez; Mayank Goyal
Journal:  J Rheumatol       Date:  2003-09       Impact factor: 4.666

Review 3.  Tuberculosis of the central nervous system: overview of neuroradiological findings.

Authors:  A Bernaerts; F M Vanhoenacker; P M Parizel; J W M Van Goethem; R Van Altena; A Laridon; J De Roeck; V Coeman; A M De Schepper
Journal:  Eur Radiol       Date:  2002-08-02       Impact factor: 5.315

4.  Potential treatment of transthyretin-type amyloidoses by sulfite.

Authors:  K Altland; P Winter
Journal:  Neurogenetics       Date:  1999-09       Impact factor: 2.660

5.  Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis.

Authors:  M Nakamura; T Yamashita; M Ueda; K Obayashi; T Sato; T Ikeda; Y Washimi; T Hirai; Y Kuwahara; M T Yamamoto; M Uchino; Y Ando
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

6.  Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis.

Authors:  M Brett; M R Persey; M M Reilly; T Revesz; D R Booth; S E Booth; P N Hawkins; M B Pepys; J A Morgan-Hughes
Journal:  Brain       Date:  1999-02       Impact factor: 13.501

Review 7.  Idiopathic hypertrophic pachymeningitis.

Authors:  M J Kupersmith; V Martin; G Heller; A Shah; H J Mitnick
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

8.  Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis.

Authors:  K Jin; S Sato; T Takahashi; H Nakazaki; Y Date; M Nakazato; T Tominaga; Y Itoyama; S Ikeda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

9.  A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.

Authors:  Yukio Ando; Hisayasu Terazaki; Masaaki Nakamura; Eiko Ando; Katsuki Haraoka; Taro Yamashita; Mitsuharu Ueda; Hiroaki Okabe; Yutaka Sasaki; Hidenobu Tanihara; Makoto Uchino; Yukihiro Inomata
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

10.  Multifocal fibrosclerosis with hypertrophic intracranial pachymeningitis.

Authors:  J R Berger; S Snodgrass; J Glaser; M J Post; M Norenberg; P Benedetto
Journal:  Neurology       Date:  1989-10       Impact factor: 9.910
View more
  3 in total

1.  Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy.

Authors:  J Linn; J Herms; M Dichgans; H Brückmann; G Fesl; T Freilinger; M Wiesmann
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-18       Impact factor: 3.825

Review 2.  Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations.

Authors:  Qi Qin; Cuibai Wei; YueShan Piao; Fang Lian; Hao Wu; Aihong Zhou; Fen Wang; Xiumei Zuo; Yue Han; Jihui Lyu; Dongmei Guo; Jianping Jia
Journal:  Neurologist       Date:  2021-09-07       Impact factor: 1.398

3.  Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.

Authors:  P McColgan; S Viegas; S Gandhi; K Bull; R Tudor; F Sheikh; J Pinney; M Fontana; D Rowczenio; J D Gillmore; J A Gilbertson; C J Whelan; S Shah; Z Jaunmuktane; J L Holton; J M Schott; D J Werring; P N Hawkins; M M Reilly
Journal:  J Neurol       Date:  2014-12-09       Impact factor: 4.849
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.